| Literature DB >> 20002893 |
Gregory S Parnell1, Christopher M Smith, Frederick I Moxley.
Abstract
The tragic events of 9/11 and the concerns about the potential for a terrorist or hostile state attack with weapons of mass destruction have led to an increased emphasis on risk analysis for homeland security. Uncertain hazards (natural and engineering) have been successfully analyzed using probabilistic risk analysis (PRA). Unlike uncertain hazards, terrorists and hostile states are intelligent adversaries who can observe our vulnerabilities and dynamically adapt their plans and actions to achieve their objectives. This article compares uncertain hazard risk analysis with intelligent adversary risk analysis, describes the intelligent adversary risk analysis challenges, and presents a probabilistic defender-attacker-defender model to evaluate the baseline risk and the potential risk reduction provided by defender investments. The model includes defender decisions prior to an attack; attacker decisions during the attack; defender actions after an attack; and the uncertainties of attack implementation, detection, and consequences. The risk management model is demonstrated with an illustrative bioterrorism problem with notional data.Entities:
Mesh:
Year: 2009 PMID: 20002893 PMCID: PMC7159100 DOI: 10.1111/j.1539-6924.2009.01319.x
Source DB: PubMed Journal: Risk Anal ISSN: 0272-4332 Impact factor: 4.000
Uncertain Hazards Versus Intelligent Adversaries
| Uncertain Hazards | Intelligent Adversaries | |
|---|---|---|
| Historical Data |
|
|
| A record exists of extreme events that have already occurred. | Events of September 11, 2001, were the first foreign terrorist attacks worldwide with such a huge concentration of victims and insured damages. | |
| Risk of Occurrence |
|
|
| Well‐developed models exist for estimating risks based on historical data and experts’ estimates. | Adversaries can purposefully adapt their strategy (target, weapons, time) depending on their information on vulnerabilities. Attribution may be difficult (e.g. anthrax attacks). | |
| Geographic Risk |
|
|
| Some geographical areas are well known for being at risk (e.g., California for earthquakes or Florida for hurricanes). | Some cities may be considered riskier than others (e.g., New York City, Washington), but terrorists may attack anywhere, any time. | |
| Information |
|
|
| New scientific knowledge on natural hazards can be shared with all the stakeholders. | Governments sometimes keep secret new information on terrorism for national security reasons. | |
| Event Type |
|
|
| To date, no one can influence the occurrence of an extreme natural event (e.g., an earthquake). | Governments may be able to influence terrorism (e.g., foreign policy; international cooperation; national and homeland security measures). | |
| Preparedness and Prevention | Government and insureds can invest in well‐known mitigation measures. | Attack methodologies and weapon types are numerous. Local agencies have limited resources to protect potentially numerous targets. Federal agencies may be in a better position to develop better offensive, defensive and response strategies. |
Modified from Kunreuther.( , ) 431–461.( )
Figure 1Event tree example.
Figure 2Decision tree example.
Figure 3Canonical bioterrorism decision tree.
Figure 4Canonical bioterrorism influence diagram.
CDC BioTerror Agent Categories( )
| Category | Definition |
|---|---|
| A | The U.S. public health system and primary healthcare providers must be prepared to address various biological agents, including pathogens that are rarely seen in the United States. High‐priority agents include organisms that pose a risk to national security because they: can be easily disseminated or transmitted from person to person; result in high mortality rates and have the potential for major public health impact; might cause public panic and social disruption; and require special action for public health preparedness. |
| B | Second highest priority agents include those that: are moderately easy to disseminate; result in moderate morbidity rates and low mortality rates; and require specific enhancements of CDC's diagnostic capacity and enhanced disease surveillance. |
| C | Third highest priority agents include emerging pathogens that could be engineered for mass dissemination in the future because of: availability; ease of production and dissemination; and potential for high morbidity and mortality rates and major health impact. |
Pathogens( , )
| National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) Category A, B, and C Priority Pathogens | ||
|---|---|---|
| Category A | Category B | Category C |
| • Bacillus anthracis (anthrax) | • Burkholderia pseudomallei | Emerging infectious disease threats such as Nipah virus and additional hantaviruses. |
| • Clostridium botulinum toxin (botulism) | • Coxiella burnetii (Q Fever) | |
| • Brucella species (brucellosis) | ||
| • Yersinia pestis (plague) | • Burkholderia mallei (glanders) |
|
| • Variola major (smallpox) and other related pox viruses | • Chlamydia psittaci (Psittacosis) | • Tickborne hemorrhagic fever viruses |
| • Ricin toxin (from Ricinus communis) | • Crimean‐Congo hemorrhagic fever virus | |
| • Francisella tularensis (tularemia) | • Epsilon toxin of Clostridium perfringens | • Tickborne encephalitis viruses |
| • Staphylococcus enterotoxin B | • Yellow fever | |
| • Viral hemorrhagic fevers | • Typhus fever (Rickettsia prowazekii) | • Multi‐drug resistant TB |
| • Arenaviruses | • Food and waterborne pathogens | • Influenza |
| • LCM, Junin virus, Machupo virus, Guanarito virus | • Bacteria | • Other Rickettsias |
| • Diarrheagenic E. coli | • Rabies | |
| • Lassa Fever | • Pathogenic Vibrios | • Prions |
| • Bunyaviruses | • Shigella species | • Chikungunya virus |
| • Hantaviruses | • Salmonella | • Severe acute respiratory syndrome associated coronavirus (SARS‐CoV) |
| • Rift Valley Fever | • Listeria monocytogenes | |
| • Flaviruses | • Campylobacter jejuni | |
| • Dengue | • Yersinia enterocolitica) | |
| • Filoviruses | • Viruses (Caliciviruses, Hepatitis A) | |
| • Ebola | • Protozoa | |
| • Marburg | • Cryptosporidium parvum | |
| • Cyclospora cayatanensis | ||
| • Giardia lamblia | ||
| • Entamoeba histolytica | ||
| • Toxoplasma | ||
| • Microsporidia | ||
| • Additional viral encephalitides | ||
| • West Nile virus | ||
| • LaCrosse | ||
| • California encephalitis | ||
| • VEE | ||
| • EEE | ||
| • WEE | ||
| • Japanese Encephalitis virus | ||
| • Kyasanur Forest virus | ||
The list of potential bioterrorism agents was compiled from both CDC and NIH/NIAID websites.
Modeling Assumptions
| Categories | Our Assumptions | Possible Alternative Assumptions |
|---|---|---|
| Uncertain Variables | Probability of acquiring the agent, detection time varies by agent | Other indications and warning |
| Decisions | Add Bio Watch city for agents A and B | Additional detection and warning systems |
| Increase vaccine reserve stocks for agent A | Increase stocks of multiple agents | |
| Deploy vaccine A | Other risk mitigation decisions | |
| Consequence Models | One casualty model for all three agents | Different casualty models for different agents |
| Risks | Casualties and economic consequences | Additional risk measures |
| Defender minimizes risk and attacker maximizes risk | Other defender and attacker objectives | |
| Solve decision tree at various budget levels | Other solution approaches |
Total Number of Strategies
| Owner | Decision | No. of Strategies |
|---|---|---|
| United States | Bio Watch | 2 |
| United States | BioShield | 3 |
| Attacker | Agent selection | 3 |
| Attacker | Target | 3 |
| United States | Deploy reserve | 2 |
| Total No. of Strategies | 108 | |
Figure 5Budget versus U.S. risk.
Figure 6Complementary cumulative distribution.
Figure 7Value of correlation and value of control.
Figure 8Rainbow diagram probability of acquiring agent A versus U.S. risk.